Aspirin/prednisone therapy ineffective in fetal loss prevention, study suggests.
This article was originally published in The Tan Sheet
Executive Summary
ASPIRIN/PREDNISONE THERAPY "NOT EFFECTIVE IN PROMOTING LIVE BIRTH" in women who have tested positive for auto-antibodies and who have suffered from past unexplained recurrent fetal loss, according to a study published in the July 17 New England Journal of Medicine. In addition, the dual treatment appears to increase the risk of premature birth and may be responsible for side effects including hypertension and diabetes mellitus, Carl Laskin, MD, University of Toronto, et al. conclude. The study was funded by the Medical Research Council of Canada.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning